Integer Holdings (FRA:WGB) Altman Z-Score: 2.82 (As of Aug. 14, 2026) — 19% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WGB Integer Holdings Corp FRA:WGB
82 GF Score
Price €107.00
GF Value €104.40
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Integer Holdings Altman Z-Score?

Integer Holdings FRA:WGB 82 Altman Z-Score is 2.82 as of Aug. 14, 2026, which is 19% above its 10-year median of 2.37. GuruFocus rates FRA:WGB with a GF Score™ of 82/100 and a GF Value™ of €104.40 (Fairly Valued). The stock has 6 warning signs investors should review. Among 808 Medical Devices & Instruments companies, Integer Holdings ranks worse than 51.98% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 2.83 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

Integer Holdings has a Altman Z-Score of 2.82, indicating it is in Grey Zones. This implies that Integer Holdings is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Integer Holdings's Altman Z-Score or its related term are showing as below:

FRA:WGB' s Altman Z-Score Range Over the Past 10 Years
Min: 0.92   Med: 2.37   Max: 3.18
Current: 2.83

During the past 13 years, Integer Holdings's highest Altman Z-Score was 3.18. The lowest was 0.92. And the median was 2.37.


Integer Holdings  (FRA:WGB) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Integer Holdings Altman Z-Score Related Terms


Integer Holdings Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Integer Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integer Holdings Altman Z-Score Chart

Integer Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.50 2.07 2.64 3.18 2.27

Integer Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 2.60 2.27 2.39 2.45

FRA:WGB vs HAE, IRTC, ESTA: Altman Z-Score Comparison

For the Medical Devices subindustry, Integer Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings Altman Z-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Altman Z-Score falls into.


FRA:WGB
82GF Score
Integer Holdings Corp FRA:WGB
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integer Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Integer Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1734+1.4*0.3021+3.3*0.0484+0.6*2.4921+1.0*0.5333
=2.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Jun. 2026:
Total Assets was €2,972 Mil.
Total Current Assets was €704 Mil.
Total Current Liabilities was €188 Mil.
Retained Earnings was €898 Mil.
Pre-Tax Income was 20.217 + 17.604 + 39.973 + 39.185 = €117 Mil.
Interest Expense was -7.375 + -7.014 + -5.782 + -6.607 = €-27 Mil.
Revenue was 402.847 + 380.237 + 403.139 + 398.473 = €1,585 Mil.
Market Cap (Today) was €3,688 Mil.
Total Liabilities was €1,480 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(703.631 - 188.478)/2971.682
=0.1734

X2=Retained Earnings/Total Assets
=897.656/2971.682
=0.3021

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(116.979 - -26.778)/2971.682
=0.0484

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3687.773/1479.808
=2.4921

X5=Revenue/Total Assets
=1584.696/2971.682
=0.5333

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Integer Holdings has a Altman Z-Score of 2.82 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 2.82 mean?
Integer Holdings (FRA:WGB) has a Altman Z-Score of 2.82 as of Aug. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Integer Holdings and its competitors. This is 19% above median its historical median of 2.37. Over the past decade, Integer Holdings' Altman Z-Score has ranged from 0.92 to 3.18. According to the industry distribution chart, Integer Holdings ranks #420 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 52%.
Is Integer Holdings' Altman Z-Score too high?
Integer Holdings' current Altman Z-Score of 2.82 is 19% above median its 10-year median of 2.37. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 3.18. The Medical Devices & Instruments industry median Altman Z-Score is 3.06. Integer Holdings' value of 2.82 is 7.7% below this industry median. Based on the distribution chart, Integer Holdings ranks #420 out of 808 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Integer Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' Altman Z-Score compare to HAE and IRTC?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #420 out of 808 companies for Altman Z-Score. This places Integer Holdings in the lower half of its industry. The industry median Altman Z-Score is 3.06. Integer Holdings' value of 2.82 is 7.7% below this benchmark. Historically, Integer Holdings' own Altman Z-Score has ranged from 0.92 to 3.18 over the past decade. While the company's 10-year median is 2.37 vs. the industry median of 3.06, Integer Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 3.06, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current Altman Z-Score of 2.82 is 7.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Integer Holdings and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current Altman Z-Score is 2.82, which is 19% above median its own 10-year median of 2.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (FRA:WGB) is currently considered Fairly Valued. The stock's GF Value™ is €104.40, compared to a current price of €107.00 — trading 2.5% above its estimated fair value. The current Altman Z-Score is 2.82, which is 19% above median its 10-year median of 2.37 and 7.7% below the Medical Devices & Instruments industry median of 3.06. Integer Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Integer Holdings (FRA:WGB), the current Altman Z-Score is 2.82 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integer Holdings (FRA:WGB) Overvalued in 2026?

Based on GuruFocus' analysis, Integer Holdings stock appears to be overvalued. The current stock price of €107.00 is trading 2.5% above its estimated GF Value™ of €104.40. GuruFocus considers Integer Holdings to be Fairly Valued.

Key valuation signals for FRA:WGB:

  • Altman Z-Score: 2.82 (19% above median its 10-year median of 2.37)
  • GF Value™: €104.40 vs. price of €107.00 (2.5% above fair value)
  • GF Score™: 82/100 with 6 warning signs
  • Industry Position: 7.7% below the Medical Devices & Instruments median (#420 of 808)

No single metric tells the full story. See the FRA:WGB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integer Holdings Business Description

Other Exchanges ITGR:USA
Address 5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
82GF Score

Get the complete analysis for FRA:WGB

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€107.00
Price
€104.40
GF Value